Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ikezaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikezaki, K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Rational Approach to Treatment of Moyamoya Disease in Childhood

Kiyonobu Ikezaki, MD, PhD

Department of Neurosurgery, Neurological Institute, Faculty of Medicine, Kyushu University, Fukuoka, Japan, nobu{at}ns.med.kyushu-u.ac.jp

Early diagnosis and treatment of moyamoya disease in children is essential to minimize residual mental and physiologic deficits. Current treatment of childhood moyamoya disease in Japan, preoperative evaluation of perfusion reserve as a surgical indication, and the role of noninvasive follow-up by magnetic resonance angiography are reported. Approximately 20% of children with definite moyamoya disease were observed or treated medically. Among surgical procedures, single indirect bypass surgery was used in approximately 30% of all patients; combinations of direct and indirect bypass surgery, 20%; and multiple-indirect bypass surgery, 18%. Both adequate understanding of the primary condition and determination of optimal treatment, including specific operative procedures, required evaluation of cerebral circulation and metabolism. Surgical indications included reduced perfusion reserve in affected brain by positron emission tomography or single photon emission tomography with administration of acetazolamide or a CO 2 load. Postoperative improvements of cerebral perfusion reserve show better correlation with disappearance of ischemic attacks than does angiographically demonstrated collateral formation. Follow-up evaluation with magnetic resonance angiography has advantages over conventional angiography because it is noninvasive and avoids general anesthesia. (J Child Neurol 2000;15:350-356).

Journal of Child Neurology, Vol. 15, No. 5, 350-356 (2000)
DOI: 10.1177/088307380001500512
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
R. M. Scott and E. R. Smith
Moyamoya Disease and Moyamoya Syndrome
N. Engl. J. Med., March 19, 2009; 360(12): 1226 - 1237.
[Full Text] [PDF]

Home page
 StrokeHome page
E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al.
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke, September 1, 2008; 39(9): 2644 - 2691.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson
Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 887S - 968S.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
A. Papavasiliou, H. Bazigou-Fotopoulou, and H. Ikeda
Familial Moyamoya Disease in Two European Children
J Child Neurol, December 1, 2007; 22(12): 1371 - 1376.
[Abstract] [PDF]

Home page
 NeurologyHome page
N. J. Ullrich, R. Robertson, D. D. Kinnamon, R. M. Scott, M. W. Kieran, C. D. Turner, S. N. Chi, L. Goumnerova, M. Proctor, N. J. Tarbell, et al.
Moyamoya following cranial irradiation for primary brain tumors in children
Neurology, March 20, 2007; 68(12): 932 - 938.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. J. Alberts, R. E. Latchaw, W. R. Selman, T. Shephard, M. N. Hadley, L. M. Brass, W. Koroshetz, J. R. Marler, J. Booss, R. D. Zorowitz, et al.
Recommendations for Comprehensive Stroke Centers: A Consensus Statement From the Brain Attack Coalition
Stroke, July 1, 2005; 36(7): 1597 - 1616.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. C. Driscoll, A. Hurlet, L. Styles, V. McKie, B. Files, N. Olivieri, C. Pegelow, B. Berman, R. Drachtman, K. Patel, et al.
Stroke risk in siblings with sickle cell anemia
Blood, March 15, 2003; 101(6): 2401 - 2404.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
E. S. Roach
Immediate Surgery for Moyamoya Syndrome?: Not Necessarily
Arch Neurol, January 1, 2001; 58(1): 130 - 132.
[Full Text] [PDF]